NEW YORK (GenomeWeb News) – Atossa Genetics today announced it has entered into a contract with preferred provider organization FedMed, giving its members access to Atossa's breast health tests.

FedMed has more than 550,000 providers in its network, including 4,000 hospitals, and more than 60,000 ancillary facilities. It serves more than 40 million Americans.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.